Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
START Carolinas is a specialized clinical research center dedicated to conducting Phase 1 oncology clinical trials, located in Charlotte, North Carolina. As a member of the global South Texas Accelerated Research Therapeutics (START) network, the facility provides patients with access to the latest investigational anticancer agents through one of the world's largest early-phase drug development programs. The center operates as a partnership between START and Oncology Specialists of Charlotte, bridging the gap between community oncology and cutting-edge clinical research. START Carolinas supports pharmaceutical and biotechnology sponsors by executing complex early-stage trials for a variety of modalities, including small molecules and immunotherapies. Their mission is to accelerate the development of new cancer treatments while providing high-quality care to patients in the Carolinas region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on START Carolinas.